ALEMBICLTD
Alembic Limited
Holding company for pharma and real estate businesses
Consumer Discretionary›Realty›Realty›Residential, Commercial Projects
alembiclimited.com(opens the company website in a new tab)Key metrics
Price as of 2026-10-16
Stock price
₹97.36
Market cap
2,497 Cr
Stock P/E
7.8
P/B
1.02
Dividend yield
2.5%
ROE (FY26)
13.0%
ROCE (FY26)
13.9%
Operating margin (FY26)
32.5%
Debt / equity (FY26)
0.0044
OCF / EBITDA (FY26)
132.7%
OCF / EBITDA (3Y)
95.1%
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
Alembic is a Vadodara-based company with two reported businesses, real estate and active pharmaceutical ingredients (API), and real estate brings in most of its revenue.
Company snapshot
34thBy market cap
Ranked among 79 companies in Residential, Commercial Projects.
Segment mix
Reportable segments as of 2024-12-31 (Standalone). Revenue share = segment revenue ÷ total revenue.
Largest segment: 88.8% of revenue
| Segment | Revenue share | Revenue | PBT | Assets |
|---|---|---|---|---|
| Active Pharmaceutical Ingredients Business | 11.2% | 6 Cr | 2 Cr | 186 Cr |
| Real Estate Business | 88.8% | 50 Cr | 25 Cr | 418 Cr |
What we see
Positives
- ✓Net margin of 132.2% — the business keeps a healthy share of every rupee it earns.
3 more signals from the filings.Sign in free to see them all
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 32 Cr | 39 Cr | 49 Cr | 51 Cr | 53 Cr | 58 Cr | 60 Cr | 50 Cr | 56 Cr | 74 Cr | 60 Cr | 49 Cr |
| Operating expenses (approx.) | 22 Cr | 28 Cr | 25 Cr | 30 Cr | 33 Cr | 32 Cr | 33 Cr | 30 Cr | 33 Cr | 47 Cr | 40 Cr | 33 Cr |
| EBITDA | 10 Cr | 12 Cr | 24 Cr | 20 Cr | 20 Cr | 26 Cr | 27 Cr | 20 Cr | 23 Cr | 27 Cr | 20 Cr | 15 Cr |
| OPM % | 31.5% | 29.7% | 49.2% | 40.2% | 37.0% | 45.6% | 45.3% | 39.4% | 41.6% | 36.9% | 33.7% | 31.7% |
| Other income | 48 Cr | 2 Cr | 2 Cr | 2 Cr | 66 Cr | 4 Cr | 3 Cr | 4 Cr | 65 Cr | 2 Cr | 2 Cr | 6 Cr |
| Interest | 0.13 Cr | 0.37 Cr | 0.48 Cr | 0.49 Cr | 0.67 Cr | 0.69 Cr | 0.62 Cr | 0.59 Cr | 0.56 Cr | 0.55 Cr | 0.57 Cr | 0.60 Cr |
| Depreciation | 2 Cr | 3 Cr | 1 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr |
| Profit before tax | 95 Cr | 62 Cr | 75 Cr | 58 Cr | 126 Cr | 67 Cr | 72 Cr | 64 Cr | 137 Cr | 63 Cr | 76 Cr | 67 Cr |
| Tax % | 4.6% | 1.5% | 3.9% | 3.4% | 3.6% | 1.9% | 4.4% | 3.1% | 6.4% | 5.2% | 11.6% | 2.5% |
| Net profit | 91 Cr | 61 Cr | 72 Cr | 56 Cr | 121 Cr | 65 Cr | 68 Cr | 62 Cr | 128 Cr | 60 Cr | 67 Cr | 65 Cr |
| EPS (₹) | ₹3.53 | ₹2.39 | ₹2.81 | ₹2.17 | ₹4.71 | ₹2.55 | ₹2.67 | ₹2.40 | ₹5.00 | ₹2.34 | ₹2.61 | ₹2.53 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 147 Cr | 125 Cr | 128 Cr | 74 Cr | 74 Cr | 78 Cr | 127 Cr | 157 Cr | 222 Cr | 240 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 140 Cr | 114 Cr | 107 Cr | 71 Cr | 62 Cr | 64 Cr | 87 Cr | 101 Cr | 128 Cr | 150 Cr | Sign in free for the trailing twelve months |
| EBITDA | 7 Cr | 11 Cr | 21 Cr | 3 Cr | 11 Cr | 14 Cr | 40 Cr | 57 Cr | 94 Cr | 90 Cr | Sign in free for the trailing twelve months |
| OPM % | 4.6% | 8.9% | 16.4% | 4.4% | 15.1% | 17.8% | 31.7% | 36.1% | 42.2% | 37.7% | Sign in free for the trailing twelve months |
| Other income | 31 Cr | 37 Cr | 29 Cr | 93 Cr | 10 Cr | 89 Cr | 64 Cr | 55 Cr | 75 Cr | 73 Cr | Sign in free for the trailing twelve months |
| Interest | 0.16 Cr | 0.17 Cr | 0.22 Cr | 0.29 Cr | 0.36 Cr | 0.39 Cr | 0.47 Cr | 1 Cr | 2 Cr | 2 Cr | Sign in free for the trailing twelve months |
| Depreciation | 5 Cr | 4 Cr | 3 Cr | 3 Cr | 4 Cr | 5 Cr | 7 Cr | 8 Cr | 11 Cr | 12 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 145 Cr | 165 Cr | 235 Cr | 329 Cr | 346 Cr | 234 Cr | 197 Cr | 278 Cr | 322 Cr | 340 Cr | Sign in free for the trailing twelve months |
| Tax % | -0.6% | 1.4% | 1.8% | 0.0% | 0.9% | 5.0% | 3.1% | 3.5% | 3.4% | 6.7% | Sign in free for the trailing twelve months |
| Net profit | 145 Cr | 163 Cr | 230 Cr | 329 Cr | 343 Cr | 222 Cr | 191 Cr | 269 Cr | 311 Cr | 317 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹5.44 | ₹6.10 | ₹8.93 | ₹12.82 | ₹13.35 | ₹8.65 | ₹7.43 | ₹10.46 | ₹12.10 | ₹12.36 | Sign in free for the trailing twelve months |
| Dividend payout % | — | — | — | — | 4.5% | 2.3% | 24.1% | 20.9% | 19.7% | 19.4% | Sign in free for the trailing twelve months |
Sign in free for the trailing twelve months
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 53 Cr | 53 Cr | 51 Cr | 51 Cr | 51 Cr | 51 Cr | 51 Cr | 51 Cr | 51 Cr | 51 Cr |
| Reserves | 858 Cr | 1,032 Cr | 1,178 Cr | 1,367 Cr | 2,246 Cr | 2,445 Cr | 2,027 Cr | 2,134 Cr | 2,287 Cr | 2,394 Cr |
| Borrowings | — | — | — | — | 0.28 Cr | — | — | 9 Cr | 14 Cr | 11 Cr |
| Other liabilities | 81 Cr | 73 Cr | 58 Cr | 53 Cr | 112 Cr | 135 Cr | 127 Cr | 134 Cr | 150 Cr | 134 Cr |
| Total liabilities | 992 Cr | 1,159 Cr | 1,288 Cr | 1,471 Cr | 2,409 Cr | 2,632 Cr | 2,205 Cr | 2,329 Cr | 2,503 Cr | 2,590 Cr |
| Fixed assets (net) | 148 Cr | 132 Cr | 131 Cr | 131 Cr | 134 Cr | 133 Cr | 132 Cr | 131 Cr | 135 Cr | 170 Cr |
| CWIP | 0.16 Cr | — | 0 Cr | 3 Cr | 6 Cr | 0.19 Cr | 0.13 Cr | 1 Cr | 0 Cr | 2 Cr |
| Investments | 732 Cr | 913 Cr | 1,098 Cr | 1,227 Cr | 2,178 Cr | 2,372 Cr | 1,943 Cr | 2,024 Cr | 2,174 Cr | 2,276 Cr |
| Loans & advances | — | — | 0.04 Cr | 0.06 Cr | 0.06 Cr | 5 Cr | 0 Cr | 0 Cr | 0 Cr | 0 Cr |
| Inventories | 51 Cr | 32 Cr | 36 Cr | 35 Cr | 54 Cr | 87 Cr | 89 Cr | 93 Cr | 99 Cr | 52 Cr |
| Trade receivables | 22 Cr | 25 Cr | 14 Cr | 9 Cr | 14 Cr | 15 Cr | 23 Cr | 20 Cr | 30 Cr | 32 Cr |
| Cash & bank | 2 Cr | 0.46 Cr | 2 Cr | 58 Cr | 6 Cr | 1 Cr | 0.93 Cr | 1 Cr | 3 Cr | 1 Cr |
| Other assets | 38 Cr | 56 Cr | 8 Cr | 7 Cr | 17 Cr | 18 Cr | 17 Cr | 59 Cr | 62 Cr | 57 Cr |
| Total assets | 992 Cr | 1,159 Cr | 1,288 Cr | 1,471 Cr | 2,409 Cr | 2,632 Cr | 2,205 Cr | 2,329 Cr | 2,503 Cr | 2,590 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 52 Cr | 24 Cr | 22 Cr | 6 Cr | -2 Cr | -18 Cr | 39 Cr | 23 Cr | 86 Cr | 120 Cr |
| Cash from investing | -47 Cr | -22 Cr | 72 Cr | 57 Cr | -35 Cr | 19 Cr | 7 Cr | 26 Cr | -27 Cr | -54 Cr |
| Cash from financing | -5 Cr | -3 Cr | -89 Cr | -6 Cr | -15 Cr | -6 Cr | -46 Cr | -48 Cr | -58 Cr | -68 Cr |
| Net cash flow | -0.02 Cr | -1 Cr | 1 Cr | 57 Cr | -52 Cr | -5 Cr | -0.24 Cr | 0.33 Cr | 1 Cr | -1 Cr |
| Free cash flow (OCF − Capex) | 37 Cr | -0.89 Cr | -2 Cr | -16 Cr | -10 Cr | -19 Cr | 39 Cr | 21 Cr | 80 Cr | 82 Cr |
Ratios
| Metric | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 15.9% | 15.2% | 19.1% | 23.2% | 15.1% | 9.4% | 9.5% | 12.7% | 13.8% | 13.9% |
| ROE % | 16.0% | 15.0% | 18.7% | 23.2% | 14.9% | 8.9% | 9.2% | 12.3% | 13.3% | 13.0% |
| Debtor days | 53 | 73 | 38 | 44 | 68 | 71 | 67 | 46 | 49 | 48 |
| Inventory days | 361 | 167 | 287 | 526 | 1679 | 3709 | 4662 | 3922 | 4521 | 1370 |
| Days payable | 105 | 85 | 199 | 193 | 551 | 823 | 914 | 1314 | 1286 | 626 |
| Cash conversion cycle | 309 | 156 | 126 | 377 | 1196 | 2957 | 3815 | 2654 | 3285 | 793 |
| OCF / EBITDA % | 768.5% | 212.4% | 102.4% | 188.3% | -19.7% | -127.4% | 96.3% | 39.9% | 92.2% | 132.7% |
| OCF / EBITDA % (3 years) | — | — | 249.1% | 144.9% | 72.1% | -48.6% | 29.0% | 39.4% | 77.5% | 95.1% |
| Debt / equity | — | — | — | — | 0.0001 | — | — | 0.0042 | 0.0062 | 0.0044 |
| Current ratio | — | — | 2.05 | 3.56 | 1.72 | 2.12 | 2.05 | 1.52 | 1.85 | 1.95 |
| Net debt / EBITDA | -0.29 | — | -0.07 | -17.78 | -0.51 | -0.08 | -0.02 | 0.14 | 0.13 | 0.10 |